IDXX (STOCKS)
Idexx Laboratories Inc
$575.090000
+12.090000 (+2.15%)
Prev close: $563.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Jonathan J. Mazelsky
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $45,589.68M
- Employees
- 11,000
- P/E (TTM)
- 43.06
- P/B (TTM)
- 27.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $4.30B |
| Benefits Costs and Expenses | $2.98B |
| Cost Of Revenue | $1.64B |
| Costs And Expenses | $2.98B |
| Gross Profit | $2.66B |
| Operating Expenses | $1.30B |
| Research and Development | $251.21M |
| Other Operating Expenses | $1.05B |
| Operating Income/Loss | $1.36B |
| Income/Loss From Continuing Operations After Tax | $1.06B |
| Income/Loss From Continuing Operations Before Tax | $1.32B |
| Income Tax Expense/Benefit | $264.73M |
| Income Tax Expense/Benefit, Current | $133.52M |
| Income Tax Expense/Benefit, Deferred | $131.20M |
| Net Income/Loss | $1.06B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.06B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.06B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $8.43M |
| Basic Earnings Per Share | $13.17 |
| Diluted Earnings Per Share | $13.08 |
| Basic Average Shares | 80,427,000 |
| Diluted Average Shares | 81,025,000 |
| Assets | $3.35B |
| Current Assets | $1.41B |
| Inventory | $377.76M |
| Prepaid Expenses | $57.90M |
| Other Current Assets | $978.17M |
| Noncurrent Assets | $1.94B |
| Fixed Assets | $747.38M |
| Intangible Assets | $109.84M |
| Other Non-current Assets | $1.08B |
| Liabilities | $1.75B |
| Current Liabilities | $1.15B |
| Accounts Payable | $110.41M |
| Wages | $212.44M |
| Other Current Liabilities | $825.96M |
| Noncurrent Liabilities | $596.56M |
| Long-term Debt | $450.00M |
| Other Non-current Liabilities | $146.56M |
| Equity | $1.61B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.61B |
| Liabilities And Equity | $3.35B |
| Net Cash Flow From Operating Activities | $1.18B |
| Net Cash Flow From Operating Activities, Continuing | $1.18B |
| Net Cash Flow From Investing Activities | -$136.24M |
| Net Cash Flow From Investing Activities, Continuing | -$136.24M |
| Net Cash Flow From Financing Activities | -$1.16B |
| Net Cash Flow From Financing Activities, Continuing | -$1.16B |
| Exchange Gains/Losses | $11.20M |
| Net Cash Flow | -$108.20M |
| Net Cash Flow, Continuing | -$119.40M |
| Comprehensive Income/Loss | $1.08B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.08B |
| Other Comprehensive Income/Loss | $24.80M |
| Other Comprehensive Income/Loss Attributable To Parent | $24.80M |